REFERENCES
- Wade A., Weller P. J. Handbook of Pharmaceutical Excipients. 2nd ed., Pharmaceutical Press, London 1994; 428–429
- Pronova Biomedical Products. Alginate Properties. Author. 1998
- Muhlen A. Z., Muhlen E. Z., Niehus H., Mehnert W. Pharm. Res. 1996; 13: 1411–1416
- Armstrong N. A. Understanding Experimental Design and Interpretation in Pharmaceutics. Ellis Horwood, New York 1990; 27–54
- Box G. E., Hunter W. G., Hunter J. S. Statistics for Experimenters. John Wiley and Sons, New York 1978; 306–351
- Montgomery D. C. Design and Analysis of Experiments. 2, John Wiley and Sons, New York 1986; 261–281
- Badwan A. A., Abumalooh A., Sallam E., Abukalaf A., Jawan O. Drug Dev. Ind. Pharm. 1985; 11: 239–256
- Lin S. Y. Calcium alginate gels in oral dosage form design. Ph.D. thesis Oregon State University, Corvallis 1990
- Tanigawara Y., Yamaoka K., Nakagawa T., Uno T. Chem. Pharm. Bull. 1982; 30: 1088–1090
- Yotsuyanagi T., Ohkubo T., Ohhashi T., Ikeda K. Chem. Pharm. Bull. 1987; 35: 1555–1563
- Takka S., Ocak O. H., Acarturk F. Eur. J. Pharm. Sci. 1998; 6: 241–246
- Qstberg T., Graffner C. Int. J. Pharm. 1994; 111: 271–282